Literature DB >> 9010181

Critical biological determinants of incorporation of non-vascularized cortical bone grafts. Quantification of a complex process and structure.

S Stevenson1, X Q Li, D T Davy, L Klein, V M Goldberg.   

Abstract

Our goal in this study was to evaluate the effects of and the interaction between the hypothesized principal determinants of the incorporation of grafts: antigenicity and treatment of the graft. We implanted fresh and frozen cortical bone grafts that were matched for both major and non-major histocompatibility complex antigens (syngeneic grafts), matched for major but not for non-major histocompatibility complex antigens (minor mismatch), and mismatched for both major and non-major histocompatibility complex antigens (major mismatch). We used a rat model with an eight-millimeter segmental defect in the femur. The construct was stabilized with a plastic plate, threaded Kirschner wires, and cerclage wires. We evaluated the grafts at one, two, and four months after implantation. We measured the immune response; assessed the incorporation of the graft with use of histological examination, biomechanical testing, and quantitative isotopic kinetics; and statistically analyzed the effects of and the interactions among three independent variables: time, the degree of matching for major histocompatibility complex antigens, and the treatment of the graft (whether it was fresh or frozen). These three independent variables had profound effects on the pattern, rate, and quality of the incorporation of the graft. Two-way and three-way interactions among these variables were also noted. Serial changes in every dependent variable were observed with time. Systemic antibody specific for donor antigens was measurable only in the serum of animals that had a major mismatch, but freezing markedly attenuated the systemic antibody response. Revascularization was profoundly affected by histocompatibility-antigen matching; the syngeneic grafts were revascularized more quickly and to a greater degree than the grafts with either a minor or a major mismatch. Freezing significantly (p < 0.001) reduced the revascularization of the syngeneic grafts but had no discernible effect on the grafts with a minor mismatch.

Entities:  

Mesh:

Year:  1997        PMID: 9010181

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  22 in total

1.  Bone grafts in craniofacial surgery.

Authors:  Mohammed E Elsalanty; David G Genecov
Journal:  Craniomaxillofac Trauma Reconstr       Date:  2009-10

2.  Surgical revascularization induces angiogenesis in orthotopic bone allograft.

Authors:  Wouter F Willems; Thomas Kremer; Patricia Friedrich; Allen T Bishop
Journal:  Clin Orthop Relat Res       Date:  2012-09       Impact factor: 4.176

3.  Remodeling of cortical bone allografts mediated by adherent rAAV-RANKL and VEGF gene therapy.

Authors:  Hiromu Ito; Mette Koefoed; Prarop Tiyapatanaputi; Kirill Gromov; J Jeffrey Goater; Jonathan Carmouche; Xinping Zhang; Paul T Rubery; Joseph Rabinowitz; R Jude Samulski; Takashi Nakamura; Kjeld Soballe; Regis J O'Keefe; Brendan F Boyce; Edward M Schwarz
Journal:  Nat Med       Date:  2005-02-13       Impact factor: 53.440

4.  Quantification of massive allograft healing with dynamic contrast enhanced-MRI and cone beam-CT: a pilot study.

Authors:  Nicole Ehrhart; Susan Kraft; David Conover; Randy N Rosier; Edward M Schwarz
Journal:  Clin Orthop Relat Res       Date:  2008-06-10       Impact factor: 4.176

5.  Periosteal progenitor cell fate in segmental cortical bone graft transplantations: implications for functional tissue engineering.

Authors:  Xinping Zhang; Chao Xie; Angela S P Lin; Hiromu Ito; Hani Awad; Jay R Lieberman; Paul T Rubery; Edward M Schwarz; Regis J O'Keefe; Robert E Guldberg
Journal:  J Bone Miner Res       Date:  2005-08-08       Impact factor: 6.741

Review 6.  Direct gene therapy for bone regeneration: gene delivery, animal models, and outcome measures.

Authors:  Gadi Pelled; Ayelet Ben-Arav; Colleen Hock; David G Reynolds; Cemal Yazici; Yoram Zilberman; Zulma Gazit; Hani Awad; Dan Gazit; Edward M Schwarz
Journal:  Tissue Eng Part B Rev       Date:  2010-02       Impact factor: 6.389

7.  The use of fresh-frozen bone in oral surgery: a clinical study of 14 consecutive cases.

Authors:  Chiara D'Aloja; Ernesto D'Aloja; Enrico Santi; Massimo Franchini
Journal:  Blood Transfus       Date:  2011-01       Impact factor: 3.443

8.  Intravenous administration of multipotent stromal cells and bone allograft modification to enhance allograft healing.

Authors:  Sharada Paudel; Wen-Han Lee; Moses Lee; Talal Zahoor; Reed Mitchell; Shang-You Yang; Haiqing Zhao; Lew Schon; Zijun Zhang
Journal:  Regen Med       Date:  2019-02-14       Impact factor: 3.806

9.  Emulating native periosteum cell population and subsequent paracrine factor production to promote tissue engineered periosteum-mediated allograft healing.

Authors:  Michael D Hoffman; Danielle S W Benoit
Journal:  Biomaterials       Date:  2015-03-18       Impact factor: 12.479

10.  Effect of zoledronic acid on lumbar spinal fusion in osteoporotic patients.

Authors:  Qirui Ding; Jian Chen; Jin Fan; Qingqing Li; Guoyong Yin; Lipeng Yu
Journal:  Eur Spine J       Date:  2017-09-01       Impact factor: 3.134

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.